Kenvue Reports First Quarter 2024 Results

Q1’24: Net Sales Increased 1.1% to $3.9 Billion with Organic Growth1 of 1.9%


Q1’24: Diluted Earnings per Share of $0.15; Adjusted Diluted Earnings per Share1 of $0.28


Reaffirms Fiscal Year...

Related Keywords

United States ,Russia ,Ukraine ,America ,Thibaut Mongon ,Asia Pacific ,Paul Ruh ,Company Board Of Directors ,Strength In Essential Health ,New York Stock Exchange ,Skin Health ,Kenvue Inc ,Research Development ,York Stock Exchange ,Company Net ,Exchange Commission ,Johnson ,Company Cash ,Company Research ,Chief Executive ,Self Care ,Essential Health ,Oral Care ,Profit Margin ,Operating Income ,Chief Financial ,Founder Shares ,Deferred Markets ,Private Securities Litigation Reform Act ,Vue Forward ,Russia Ukraine War ,Middle East ,Annual Report ,Quarterly Reports ,Consolidated Statement ,Millions Except Per Share Data ,Three Months Ended March ,Three Months Ended April ,Segment Net Sales ,Adjusted Operating ,Care Adjusted ,Beauty Adjusted ,Health Adjusted ,Geographic Region ,Markets ,